Garcia Bartels 2011.
Study characteristics | ||
Methods |
Study design: monocentric, prospective, randomised, clinical non‐pharmaceutical study Study conducted: September to December 2009 Treatment arms: 2 AD follow‐up: 4 weeks |
|
Participants |
Randomised: N = 44 (Group L using lotion n = 20; Group WL without lotion n = 24) Inclusion criteria:
Exclusion criteria:
|
|
Interventions | Both groups went swimming weekly for 4 weeks for 25 to 40 minutes at the Charité‐Universitätsmedizin Berlin physiotherapy facilities. Both groups received a standard skin care regimen: weekly bathing in tap water, diaper care with water and cotton cloth or Bübchen® Comfort sensitive wipes. No skin care was performed 12 hours before evaluations Intervention: in group L (lotion group), baby skin care lotion was applied to the entire body once weekly after swimming and the skin was dried with a towel Comparator: no lotion or other skin care product was applied in Group WL (without lotion) Moisturiser/Emollient ingredients: Bübchen® Pflege Lotion: aqua, Helianthus annuus seed oil, isopropyl palmitate, dicaprylyl ether, ethylhexyl stearate, polyglyceryl‐3 polyricinoleate, glycerin, butylene glycol, octyldodecanol, polyglyceryl‐3 diisostearate, parfum, zinc stearate, chamomilla‐recutita extract, tocopheryl acetate, glyceryloleate, magnesium sulfate, tocopherol |
|
Outcomes |
Measured on 4 anatomical test areas (forehead, abdomen, buttock, thigh), using the non‐invasive Multi‐Probe Adapter System MPA® (Courage & Khazaka Electronic, GmbH, Cologne, Germany) at 6 study visits. Baseline visit (V0) was within 4 weeks before the first swimming session. After baseline, visits were performed weekly before swimming sessions (V1 to V4). No swimming took place at follow‐up, 1 week after the last swimming session (V5) Adverse events: method of collection of adverse events is not recorded "Neonatal skin condition score (NSCS) was found to be mainly normal (score 3). A mildly elevated NSCS (4) was found in < 7.5% of infants per visit, and depending on area, an NSCS of 5 was found only once at baseline visit on the thigh (data not shown). NSCS was statistically comparable at all test regions in both groups throughout the study period (n = 44). The overall occurrence of adverse events (AEs) was lower in group L (n = 18) than in group WL(n = 33, Table 3). The occurrence of diaper dermatitis, however, was similar in both groups (n = 9). After dichotomisation of subjects into the two groups “no AE at all” vs “at least one AE”, χ² test showed significantly less occurrence of AEs in group L compared to group WL (55.0% vs 83.3%; P = 0.04; Figure 8)" |
|
Identification |
Country: Germany Setting: Charité‐Universitätsmedizin Berlin, Germany, physiotherapy facilities Sponsorship source: the clinical study was sponsored by Bübchen Deutschland |
|
Declarations of interest | Prof. Blume‐Peytavi has received presentation fees from Bübchen Deutschland, which sponsored the study | |
Notes |